TotalMarketCap

GRI Bio

GRINasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$3.454 M

$1.58 +10.49%

Close of 6 Nov 2026

As of 6 Nov 2026, GRI Bio (GRI) has a market capitalization of $3.45M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$12.0M

Loss-making

Shares outstanding

2,186,115

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #462RedHill BiopharmaRDHL$3.73M
  2. #463Cadrenal TherapeuticsCVKD$3.57M
  3. #464GRI BioGRI$3.45M
  4. #465Medicus PharmaMDCX$3.45M
  5. #466Traws PharmaTRAW$3.38M

What if GRI Bio were worth as much as…

Open the what-if tool →

Gold $28.2T

$12,916,462

Per share 8,174,976× higher

Bitcoin $1.53T

$698,887.27

Per share 442,334× higher

Apple $5.02T

$2,294,382

Per share 1,452,140× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for GRI Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.